Haleon (NYSE:HLN) Upgraded by Zacks Research to Hold Rating

Zacks Research upgraded shares of Haleon (NYSE:HLN) from a strong sell rating to a hold rating in a report published on Wednesday,Zacks.com reports.

Several other research firms have also weighed in on HLN. Wall Street Zen raised Haleon from a “hold” rating to a “buy” rating in a research note on Sunday, July 12th. Rothschild & Co Redburn cut Haleon from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, June 16th. Morgan Stanley reiterated an “overweight” rating on shares of Haleon in a research report on Thursday, August 6th. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Haleon in a research note on Thursday, April 30th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Haleon in a research note on Tuesday, June 30th. Two investment analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy”.

Haleon Price Performance

NYSE:HLN opened at $9.87 on Wednesday. The company has a quick ratio of 0.52, a current ratio of 0.69 and a debt-to-equity ratio of 0.38. Haleon has a 12-month low of $8.65 and a 12-month high of $11.28. The stock’s fifty day simple moving average is $9.67 and its 200-day simple moving average is $9.82. The firm has a market capitalization of $43.47 billion, a P/E ratio of 25.31, a P/E/G ratio of 1.97 and a beta of 0.12.

Haleon Cuts Dividend

The company also recently declared a dividend, which will be paid on Thursday, September 17th. Stockholders of record on Friday, August 14th will be issued a $0.0642 dividend. This represents a dividend yield of 132.0%. The ex-dividend date is Friday, August 14th. Haleon’s payout ratio is 30.77%.

Hedge Funds Weigh In On Haleon

A number of large investors have recently bought and sold shares of HLN. Kahn Brothers Group Inc. acquired a new position in Haleon during the second quarter worth $544,000. Public Employees Retirement System of Ohio bought a new stake in Haleon during the 2nd quarter worth about $7,217,000. Wallace Capital Management Inc. acquired a new position in shares of Haleon during the 2nd quarter worth about $110,000. Fiduciary Financial Group LLC acquired a new stake in shares of Haleon in the second quarter valued at about $97,000. Finally, GAMMA Investing LLC boosted its position in Haleon by 18.1% during the second quarter. GAMMA Investing LLC now owns 34,810 shares of the company’s stock valued at $325,000 after purchasing an additional 5,338 shares during the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Company Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.